Company news
ADMA Biologics Inc news in 2023
ADMA Biologics Inc's news releases, calls and decks from 2023, newest first.
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 17, 2023
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
December 11, 2023
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 15, 2023
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 7, 2023
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
October 31, 2023
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 8, 2023
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 1, 2023
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 18, 2023
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 9, 2023
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 2, 2023
ADMA Biologics Announces Amendment to Credit Agreement
May 1, 2023
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 22, 2023
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 15, 2023
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 7, 2023
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
January 16, 2023